| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |